Samsung Medical Center
Samsung Medical Center
Republic of Korea, Seoul
Ki Woong Sung
28 years of experience
Clinic is certified :
Retinoblastoma treatment cost in the Republic of Korea typically includes complex diagnostics of retinoblastoma ranging from $1,900 to $3,100 and primary therapeutic options like cryotherapy, which runs from $6,800 to $14,500. Total expenses depend on the clinical stage, facility tier, and the need for combined chemotherapy. Patients can save approximately 40-60% compared to US costs. Seoul remains the primary destination for specialized pediatric oncology.
Typical Retinoblastoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: Early-stage patients requiring high-precision care benefit from centers like Samsung Medical Center. It operates a Comprehensive Cancer Center with presidential standards and Novalis technology. For families prioritizing safety, Seoul National University Bundang Hospital uses the BESTcare system to eliminate medical errors. Advanced cases requiring multidisciplinary expertise are best served at Severance Hospital (JCI-accredited), which manages 4 million outpatients annually.
| Republic of Korea | Turkey | Austria | |
| High intensity focused ultrasound ablation (HIFU) | from $12,500 | from $4,000 | from $12,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Cryotherapy | from $6,800 | from $250 | from $8,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Photocoagulation | - | from $250 | from $750 |
No hidden fees – just official clinic prices. Pay at the clinic for Retinoblastoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Retinoblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Retinoblastoma treatment journey.
The doctor is an ophthalmologist specializing in strabismus and pediatric ophthalmology. With extensive experience in treating eye disorders in children, the doctor focuses on correcting misalignment of the eyes and improving vision-related issues in young patients. The doctor is recognized for their expertise in innovative surgical techniques and comprehensive eye care.
The doctor is a pediatrician with a specialization in bone marrow transplantation and brain tumor treatment. Graduating with a Bachelor of Medicine, a Master's degree, and a PhD from Seoul National University, the doctor has extensive experience in both clinical practice and research.
Professional experience includes serving as a pediatrician at Samsung Medical Center, an Assistant Professor in the Department of Pediatrics at Samsung Clinic, and a researcher at the Oncology Center of Indiana University School of Medicine. The doctor has held leadership roles such as Head of the Children's Oncology Department at Samsung Hospital and currently serves as Head of the Department of Pediatrics at Samsung Clinic.
Top Korean hospitals for retinoblastoma include Samsung Medical Center, Seoul National University Bundang Hospital, and Severance Hospital. These Seoul-based tertiary centers utilize image-guided radiation therapy and cryotherapy. They provide essential multidisciplinary care. JCI and KOIHA accreditations ensure high safety standards for international pediatric oncology patients.
Bookimed Expert Insight: Retinoblastoma cases in Korea are concentrated in large academic centers like Severance and Samsung. These facilities handle massive patient volumes, with Severance seeing 4,000,000 outpatients annually. This high frequency allows surgeons to maintain specialized skill sets specifically for rare pediatric eye cancers. You should choose these high-volume centers to ensure the ophthalmology and oncology teams work together daily.
Patient Consensus: Patients emphasize finding a hospital that can provide rapid diagnostic imaging and same-week evaluation. They note that having pediatric anesthesia and oncology in one system is vital for young children.
Modern retinoblastoma treatment in South Korea utilizes advanced eye-saving protocols like intra-arterial chemotherapy and cryotherapy. JCI-accredited centers in Seoul prioritize preserving vision through multidisciplinary care. Specialized ocular oncology teams employ high-intensity focused ultrasound ablation and laser therapies to target tumors while minimizing systemic toxicity.
Bookimed Expert Insight: Clinical data from Seoul's major medical complexes reveals a massive focus on high-volume oncology expertise. Severance Hospital alone serves over 4,000,000 patients annually. This massive scale allows Korean teams to maintain specialized pediatric ocular oncology units that are rare in smaller medical markets.
Patient Consensus: Patients note that choosing a center with a dedicated pediatric team is vital. Many emphasize that intra-arterial and intravitreal chemotherapy are the most sought-after options for preventing eye removal.
South Korean university hospitals house specialized multidisciplinary teams for pediatric eye cancer. These centers combine pediatric oncology and ophthalmology to treat retinoblastoma. Top facilities like Samsung Medical Center and Severance Hospital utilize advanced technologies like Novalis and image-guided radiation therapy to preserve vision.
Bookimed Expert Insight: Retinoblastoma care in Korea is concentrated in high-volume academic centers rather than small clinics. Severance Hospital alone manages 4 million outpatients annually. This massive scale allows major university hospitals to maintain dedicated retinoblastoma pathways. These pathways ensure pediatric anesthesia, imaging, and oncology coordination happen in one building. This centralized approach is why Korea maintains a global rank of 4 for medical requests.
Patient Consensus: Parents find that major university hospitals are the only centers equipped for complex pediatric anesthesia during eye scans. They advise choosing a facility that has a specific team for eye tumors rather than just a general ophthalmology department.
Korean oncology centers report high survival rates for retinoblastoma, reaching approximately 93.9% over 10 years. Specialized centers focus on advanced globe-salvage techniques like intra-arterial chemotherapy. These methods successfully preserve the eye in nearly 50% of primary cases and 75% when combined with radiotherapy.
Bookimed Expert Insight: Korea's clinical strength lies in its digital-first infrastructure. For example, Seoul National University Bundang Hospital uses the BESTcare system to minimize medical errors. This technological layer ensures that complex pediatric dosages for chemotherapy are highly precise, which directly supports the country's superior safety record in life salvage compared to other Asian regions.
Patient Consensus: Parents emphasize that while cancer control is often successful, visual recovery is not guaranteed. They recommend choosing multidisciplinary teams involving both pediatric oncologists and ophthalmologists to manage the intensive follow-up schedule effectively.
Clinical trials for novel retinoblastoma therapies are accessible at major South Korean tertiary hospitals. Academic centers like Severance Hospital and Samsung Medical Center conduct research on intra-arterial chemotherapy and intravitreal injections. These trials focus on eye salvage and reducing treatment side effects for pediatric patients.
Bookimed Expert Insight: Success in finding a trial slot in Korea often depends on clinic volume. Severance Hospital treats approximately 1.6 million outpatients annually and holds JCI accreditation. This massive patient flow typically correlates with more active research protocols compared to smaller centers. If a specific trial is full, these large academic institutions often have established networks to refer patients to international study sites quickly.
Patient Consensus: Families note that while Korea has advanced hospitals, trial windows for rare pediatric cancers are often very narrow. They advise asking tertiary children's hospitals directly about compassionate use or international referral options if local slots are closed.